Verona Pharma
Focus: Verona Pharma is a public UK-based specialty pharmaceutical company focused on small-molecule respiratory therapeutics. The company operates at mid-market scale with 456 active job openings, indicating active expansion.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
791+259 this month
Hot — 949 jobs added in 30d
Net +259 (949 new, 690 removed). Aggressive expansion phase.
Should You Work at Verona Pharma?
AI assessmentVerona offers stability through an approved respiratory asset but faces pipeline credibility concerns and limited portfolio diversification.
Why Work Here
- Lead product OHTUVAYRE (ensifentrine) is in growth phase with LOE protection until 2044, providing long-term job security
- Actively hiring 456 roles across Commercial, R&D, and Clinical Operations signals company expansion and career advancement opportunity
Data completeness
6/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Help build intelligence for Verona Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.